Tg Therapeutics (TGTX) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $2.69.
- Tg Therapeutics' EPS (Basic) rose 886666.67% to $2.69 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.07, marking a year-over-year increase of 351111.11%. This contributed to the annual value of $0.16 for FY2024, which is 7777.78% up from last year.
- Tg Therapeutics' EPS (Basic) amounted to $2.69 in Q3 2025, which was up 886666.67% from $0.19 recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' EPS (Basic) ranged from a high of $2.69 in Q3 2025 and a low of -$0.7 during Q4 2021
- Moreover, its 5-year median value for EPS (Basic) was -$0.26 (2022), whereas its average is -$0.06.
- Per our database at Business Quant, Tg Therapeutics' EPS (Basic) tumbled by 9625.0% in 2024 and then soared by 886666.67% in 2025.
- Over the past 5 years, Tg Therapeutics' EPS (Basic) (Quarter) stood at -$0.7 in 2021, then increased by 18.57% to -$0.57 in 2022, then skyrocketed by 82.46% to -$0.1 in 2023, then soared by 260.0% to $0.16 in 2024, then surged by 1581.25% to $2.69 in 2025.
- Its last three reported values are $2.69 in Q3 2025, $0.19 for Q2 2025, and $0.03 during Q1 2025.